Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zai Lab (ZLAB) has issued an update.
Zai Lab Limited has announced the retirement of Dr. Harald Reinhart, Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases, effective June 30, 2024, with no disagreements prompting his departure. Concurrently, Dr. Rafael Amado will take over as Head of Global Research and Development, expanding his current role in Oncology Research, ensuring a seamless transition in leadership.
See more insights into ZLAB stock on TipRanks’ Stock Analysis page.